A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone-Reference-Cited by-同舟云学术

A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone

Published:2018-04-16 Issue:4 Volume:181 Page:476-485
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Jimenez Joaquin J.¹²^ORCID,DelCanto Gina M.²,Popovics Petra³⁴,Perez Aymee⁵,Vila Granda Ailin¹,Vidaurre Irving⁴,Cai Ren-Zhi³⁴,Rick Ferenc G.⁴⁶,Swords Ronan T.⁵⁷,Schally Andrew V.³⁴⁵⁷⁸

Affiliation:

1. Department of Dermatology and Cutaneous Surgery; Miller School of Medicine; University of Miami; Miami FL USA

2. Department of Biochemistry and Molecular Biology; Miller School of Medicine; University of Miami; Miami FL USA

3. Division of Endocrinology; Department of Medicine; Miller School of Medicine; University of Miami; Miami FL USA

4. Veterans Affairs Medical Center; Miami FL USA

5. Sylvester Comprehensive Cancer Center; Department of Medicine; Miller School of Medicine; University of Miami; Miami FL USA

6. Department of Urology; Herbert Wertheim College of Medicine; Florida International University; Miami FL USA

7. Division of Hematology/Oncology; Department of Medicine; Miller School of Medicine; University of Miami; Miami FL USA

8. Department of Pathology; Miller School of Medicine; University of Miami; Miami FL USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15207/fullpdf

Reference30 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice;Chatzistamou;The Journal of Clinical Endocrinology and Metabolism,2001a

3. Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone;Chatzistamou;Anti-Cancer Drugs,2001b

4. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells;Chu;Proceedings of the National Academy of Sciences of the United States of America,2016

5. Molecular therapy for acute myeloid leukaemia;Coombs;Nature Reviews Clinical Oncology,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and applications of peptide–agent conjugates for targeting tumor cells;Journal of Cancer Research and Clinical Oncology;2023-08-15

2. The Application of GHRH Antagonist as a Treatment for Resistant APL;Cancers;2023-06-08

3. The potential role of the thymus in immunotherapies for acute myeloid leukemia;Frontiers in Immunology;2023-02-06

4. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs;Biotechnology and Genetic Engineering Reviews;2022-06-14

5. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity;Peptides;2022-04